Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05635266 · ClinicalTrials.gov registry record
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
A clinical trial of Asthma and Alzheimer Disease, sponsored by Sanguine Biosciences.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT05635266: Recruiting study of Asthma and Alzheimer Disease, sponsored by Sanguine Biosciences.
NCT05635266 is a study of Asthma and Alzheimer Disease that is actively recruiting participants, run by Sanguine Biosciences. The registered enrollment target is 20,000 participants, above the 1,510-participant average among 374 other Asthma trials with a reported enrollment target (1225% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05635266, a study of Asthma and Alzheimer Disease, is actively recruiting participants, sponsored by Sanguine Biosciences.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Specimen sample
Study Locations (1)
Massachusetts
- Sanguine Biosciences - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2021-10-26 |
| Est. Completion | 2025-10 |
What NCT05635266 shows while recruiting
NCT05635266 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,510-participant average among 374 other Asthma trials with a reported enrollment target (1225% higher).
The record links to 10 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Specimen sample is the first listed.
NCT05635266 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05635266 about?
NCT05635266 is a clinical study titled "Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives". To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.
What is the current status of trial NCT05635266?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2021-10-26. Estimated completion is 2025-10.
What conditions does trial NCT05635266 study?
This clinical trial studies the following conditions: Asthma, Alzheimer Disease, Atopic Dermatitis, Age-related Macular Degeneration, Arthritis.
What interventions are being tested in trial NCT05635266?
The interventions under investigation include: Specimen sample (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05635266?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05635266 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05635266's enrollment target sits among peer trials
20,000 6th of 374 higher than 369 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI